• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.08% Nasdaq Down 0.35%

    Novavax, Inc. (NVAX)

    -NasdaqGS
    4.62 Down 0.03(0.65%) Feb 9, 4:00PM EST
    |After Hours : 4.67 Up 0.05 (1.08%) Feb 9, 6:04PM EST
    Prev Close:4.65
    Open:4.51
    Bid:4.67 x 300
    Ask:5.00 x 200
    1y Target Est:16.35
    Beta:1.8243
    Earnings Date:Feb 24 - Feb 29 (Est.)
    Day's Range:4.35 - 4.85
    52wk Range:4.08 - 15.01
    Volume:8,617,896
    Avg Vol (3m):6,905,500
    Market Cap:1.25B
    P/E (ttm):N/A
    EPS (ttm):-0.43
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NVAX

    Comparison

    Symbol% ChgMkt Cap
    NVAXDown 0.65%1.25B
    MRKUp 0.68%137.33B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):33.80
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.44
    Quarterly EPS Est (Dec-15) :-0.14
    Mean Recommendation*:1.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback